What is the treatment for Pertussis (whooping cough)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment of pertussis (whooping cough) involves antibiotics, supportive care, and preventive measures, with macrolide antibiotics being the first-line treatment, and azithromycin being the preferred choice. The preferred dosing for azithromycin is 10 mg/kg on day 1, then 5 mg/kg daily for days 2-5 for children, and 500 mg on day 1, then 250 mg daily for days 2-5 for adults 1. Alternatives to azithromycin include clarithromycin and erythromycin, with dosing as follows: clarithromycin (15 mg/kg/day divided twice daily for 7 days in children; 500 mg twice daily for 7 days in adults) and erythromycin (40-50 mg/kg/day divided four times daily for 14 days in children; 500 mg four times daily for 14 days in adults) 1. For patients who cannot tolerate macrolides, trimethoprim-sulfamethoxazole is an option.

Antibiotics are most effective when started within the first 2-3 weeks of symptoms and help reduce transmission, though they may not significantly alter the course of illness if started later. Supportive care includes:

  • Maintaining hydration
  • Managing coughing episodes
  • Ensuring adequate nutrition
  • Monitoring for complications like pneumonia or apnea, particularly in infants. Hospitalization may be necessary for severe cases, especially in infants under 6 months. Household contacts should receive prophylactic antibiotics regardless of vaccination status, and vaccination remains the best prevention strategy for this bacterial respiratory infection caused by Bordetella pertussis 1.

From the Research

Treatment Options for Pertussis

  • The primary treatment for pertussis involves the use of antibiotics to eradicate nasal bacterial carriage and reduce transmission rates 2, 3, 4, 5, 6.
  • Macrolide antibiotics, such as azithromycin, are considered first-line treatments for pertussis, with alternatives including trimethoprim/sulfamethoxazole for patients with allergies or intolerance to macrolides 2, 5, 6.
  • Erythromycin is also an accepted treatment option, although it may have more side effects and lower compliance compared to newer macrolides like clarithromycin and azithromycin 3, 4, 5, 6.
  • Short-term antibiotic regimens, such as 3-day azithromycin or 7-day clarithromycin, have been shown to be equally effective as long-term regimens (14-day erythromycin) in microbiological eradication and clinical improvement 4, 5.

Antibiotic Regimens

  • Effective antibiotic regimens for pertussis include:
    • 3 days of azithromycin
    • 7 days of clarithromycin
    • 7 or 14 days of erythromycin estolate
    • 14 days of erythromycin ethylsuccinate
    • 7 days of trimethoprim/sulfamethoxazole (as an alternative for patients who cannot tolerate macrolides) 5
  • These regimens can help eliminate B. pertussis from patients, reducing the risk of transmission to others 2, 3, 5, 6.

Supportive Treatment

  • Supportive treatment, including nasopharyngeal suction, oxygen, and parenteral fluids, is essential for infants under 1 year who are at greatest risk of complications and permanent sequelae 3.
  • Steroids and beta2-agonists may also be used in the management of severe neonatal pertussis 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pertussis: a reemerging infection.

American family physician, 2013

Research

Current pharmacotherapy of pertussis.

Expert opinion on pharmacotherapy, 2001

Research

Antibiotics for whooping cough (pertussis).

The Cochrane database of systematic reviews, 2005

Research

Use of antibiotics in the prevention and treatment of pertussis.

The Pediatric infectious disease journal, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.